PRESS RELEASE Fennec Pharmaceuticals Announces Investigator-Sponsored Study to be Conducted by University of Arizona Cancer Center
Today we announced the initiation of an IST by University of Arizona Cancer Center to evaluate use of PEDMARK® (sodium thiosulfate injection). Learn more: bit.ly/4mdtNEh
#ClinicalResearch #ComprehensiveCancerCare #OncoSky
1
0
1
0
